Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations.

ABSTRACT: Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the real-world population on factors that induce HTE, the trials effect will not replicate. The RCTs eligibility criteria should identify the sub-population in which its evidence will replicate. However, the extent to which the eligibility criteria identify the appropriate population is unknown, which raises concerns for generalizability. We compared reported data from RCTs with real-world data from the electronic health records of a large, academic medical center that was curated according to RCT eligibility

SUBMITTER: Averitt AJ 

PROVIDER: S-EPMC7214444 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature